title: alpha 2-, alpha 2A-, alpha 2B/2C-Adrenoceptor subtype antagonists prevent lipopolysaccharide-induced fever response in rabbits.
abstract: Exogenous pyrogens, e.g., bacterial lipopolysaccharides (LPS), are thought to stimulate macrophages to release endogenous pyrogens, e.g., TNF alpha, IL-1 beta, and IL-6, which act in the hypothalamus to produce fever. We studied the effect of different alpha 1- and alpha 2-adrenoceptor subtype antagonists, applied intraperitoneally, on the febrile response induced by LPS in rabbits. Evidence was obtained that prazosin, an alpha 1- and alpha 2B/2C-adrenoceptor antagonist; WB-4101, an alpha 1- and alpha 2A-adrenoceptor antagonist; CH-38083, a highly selective alpha 2-adrenoceptor antagonist (alpha 2:alpha 1 > 2000); BRL-44408, an alpha 2A-adrenoceptor antagonist; and ARC-239, an alpha 2B/2C- and also alpha 1-adrenoceptor antagonist, blocked the increase of colonic temperature of the rabbit produced by 2 micrograms/kg LPS administered intravenously without being able in themselves to affect colonic temperature. In addition, prazosin, WB-4101 and CH-38083 antagonized the fall in skin temperature that occurred at the time when the colonic temperature was rising in control animals injected with LPS. All these results suggest that norepinephrine, through stimulation of both alpha 1- and alpha 2- (alpha 2A- and alpha 2B/2C-) adrenoceptor subtypes, is involved in producing fever in response to bacterial LPS.
authors.affiliation: Institute of Experimental Medicine, Hungarian Academy of Sciences, Budapest, Hungary.
authors.forename: A
authors.initials: A
authors.lastname: Bencsics
authors.forename: I J
authors.initials: IJ
authors.lastname: Elenkov
authors.forename: E S
authors.initials: ES
authors.lastname: Vizi
mesh_terms: D058668:Adrenergic alpha-1 Receptor Antagonists; D058669:Adrenergic alpha-2 Receptor Antagonists; D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology*; D000818:Animals; D001831:Body Temperature / Q000502:physiology; D004146:Dioxanes / Q000494:pharmacology; D005334:Fever / Q000139:chemically induced / Q000188:drug therapy* / Q000503:physiopathology; D007093:Imidazoles / Q000494:pharmacology; D007211:Indoles / Q000494:pharmacology; D007275:Injections, Intravenous; D054833:Isoindoles; D007546:Isoquinolines / Q000494:pharmacology; D008070:Lipopolysaccharides / Q000494:pharmacology; D008297:Male; D010879:Piperazines / Q000494:pharmacology; D011224:Prazosin / Q000494:pharmacology; D011817:Rabbits; D018341:Receptors, Adrenergic, alpha-2 / Q000648:ultrastructure; D012879:Skin Physiological Phenomena
chemical_list: D058668:Adrenergic alpha-1 Receptor Antagonists; D058669:Adrenergic alpha-2 Receptor Antagonists; D000317:Adrenergic alpha-Antagonists; D004146:Dioxanes; D007093:Imidazoles; D007211:Indoles; D054833:Isoindoles; D007546:Isoquinolines; D008070:Lipopolysaccharides; D010879:Piperazines; D018341:Receptors, Adrenergic, alpha-2; C010654:(2-(2',6'-dimethoxy)phenoxyethylamino)methylbenzo-1,4-dioxane; C032994:AR-C239; D011224:Prazosin; C072125:BRL 44408